Koyfin Home > Directory > Health Care > Nymox Pharm Corp > Total Debt / (EBITDA-CAPEX)

Nymox Pharm Corp Total Debt / (EBITDA-CAPEX) Chart (NYMX)

Nymox Pharm Corp annual/quarterly Total Debt / (EBITDA-CAPEX) from 2014 to 2020.
  • Nymox Pharm Corp Total Debt / (EBITDA-CAPEX) for the quarter ending June 06, 2020 was $0m a -56.28% increase of 0m year over year
  • Nymox Pharm Corp Total Debt / (EBITDA-CAPEX) for the last 12 months ending June 06, 2020 was $0m a -5.88% increase of 0m year over year
  • Nymox Pharm Corp Annual Total Debt / (EBITDA-CAPEX) for 2019 was $0m a -515.59% increase of 0m from 2018
  • Nymox Pharm Corp Annual Total Debt / (EBITDA-CAPEX) for 2016 was $0m a 36.27% decrease of 0m from 2015
  • Nymox Pharm Corp Annual Total Debt / (EBITDA-CAPEX) for 2015 was $0m a -230.19% increase of 0m from 2014
Other Ratios Metrics:
  • Nymox Pharm Corp Total Debt / Capital for the quarter ending September 09, 2017 was $98m a 78.16% increase of 77m year over year
  • Nymox Pharm Corp Other Liabilities for the quarter ending December 12, 2016 was $0m a 208,053.10% decrease of -2m year over year
  • Nymox Pharm Corp Total Debt / Equity for the quarter ending September 09, 2017 was $6,192m a 99.37% increase of 6,153m year over year
View Chart On Koyfin

Quarterly NYMX Total Debt / (EBITDA-CAPEX) Data

06/2020$0m
03/2020$0m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m
09/2017$0m
06/2017$0m
03/2017$0m
12/2016$0m

Annual NYMX Total Debt / (EBITDA-CAPEX) Data

2019$0m
2016$0m
2015$0m
2014$0m